Objective: To explore vestibular integrity by bone vibration-induced nystagmus (VIN) during bedside examination. Disease or dysfunction of vestibular end organs would reduce or eliminate their contribution to total eye movement response to VIN. Background: It is assumed that vibration of the mastoid (at a frequency of 100 Hz) stimulates all vestibular end organs (semicircular canals and otolith structures). Previous studies have described oculomotor responses to vestibular activation by vibratory stimulus. Stimulation of individual semicircular canals produces eye movement in the plane of the stimulated canal. Vibratory stimulation of otolith structures (utricular macula) produces changes in ocular torsional position. Superior semicircular canal dehiscence (SCD) is responsible for nontypical cochleovestibular symptoms. Diagnosis is difficult without resorting to imaging, high-resolution computed tomography (HRCT) being the only tool providing reliable assessment. To avoid unnecessary referral for expensive imaging, it would be useful to have a simple screening test to select cases for HRCT. Methods: Video eye movements were recorded in complete darkness in patients diagnosed with SCD. The eye movement responses to long-lasting unilateral vibratory stimulation applied to the mastoid surface were evaluated. Results: VIN evoked a response in all cases, mostly demonstrating excitation of the affected side. The pattern of vertical, torsional and horizontal eye velocity and eye position was evaluated with three-dimensional infrared video-oculography (50 Hz sampling). Conclusion: Analysis of VIN, recently proposed to study transmission of excitatory stimuli by bone conduction, may be appropriate for altered immittance caused by dehiscence. This promises to be an interesting new field of research.

1.
Belden CJ, Weg N, Minor LB, Zinreich SJ: CT evaluation of bone dehiscence of the superior semicircular canal as a cause of sound- and/or pressure-induced vertigo. Radiology 2003;226:337–343.
2.
Brantberg K, Bergenius J, Tribukait A: Vestibular-evoked myogenic potentials in patients with dehiscence of the superior semicircular canal. Acta Otolaryngol 1999;119:633–640.
3.
Christensen-Dalsgaard J, Narins PM: Sound and vibration sensitivity of VIIIth nerve fibers in the frogs Leptodactylus albilabris and Rana pipiens pipiens. J Comp Physiol 1993;172:653–662.
4.
Cremer PD, Minor LB, Carey JP, Della Santina CC: Eye movements in patients with superior canal dehiscence syndrome align with the abnormal canal. Neurology 2000;55:1833–1841.
5.
Dumas G, Lavieille JP, Schmerber S: Vibratory test and head shaking test and caloric test: a series of 87 patients. Ann Otolaryngol Chir Cervicofac 2004;121:22–32.
6.
Dumas G, Michel J: Valeur sémiologique du test de vibration osseux cranien. Compte rendu des séances de la Societé d’Otoneurologie de langue française, XXXI symposium, Liège, 1997.
7.
Dumas G, Perrin P, Morel N, N’Guyen D-Q, Schmerber S: Skull vibratory test in partial vestibular lesions – influence of the stimulus frequency on the nystagmus direction. Rev Laryngol Otol Rhinol 2005;4:235–242.
8.
Ewald JR: Physiologische Untersuchungen über den Gang des Nervus octavus. Wiesbaden, Bergmann, 1892.
9.
Freeman S, Sichel JY, Sohmer H: Bone conduction experiments in animals: evidence for a non-osseous mechanism. Hear Res 2000;146:72–80.
10.
Halmagyi GM, Curthoys IS, Colebatch JG, Aw ST: Vestibular responses to sound. Ann NY Acad Sci 2005;1039:1–14.
11.
Hamann KF, Schuster EM: Vibration induced nystagmus: a sign of unilateral vestibular deficit. ORL J Otorhinolaryngol Relat Spec 1999;61:74–79.
12.
Karlberg M, Aw ST, Black RA, Todd MJ, MacDougall HG, Halmagyi GM: Vibration-induced ocular torsion and nystagmus after unilateral vestibular deafferentation. Brain 2003;126:956–964.
13.
Lackner JR: Elicitation of vestibular side effects by regional vibration of head. Aerospace Med 1974;45:1267–1272.
14.
Lücke K: Eine Methode zur Provokation eines pathologischen Nystagmus durch Vibrations-Reize von 100 Hz. Z Laryngol Rhinol Otol 1973;52:716–720.
15.
Minor LB: Clinical manifestations of superior semicircular canal dehiscence. Laryngoscope 2005;115:1717–1727.
16.
Minor LB, Solomon D, Zinreich JS, Zee DS: Sound- and/or pressure-induced vertigo due to bone dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg 1998;124:249–258.
17.
Ohki M, Murofushi T, Nakahara H, Sugasawa K: Vibration-induced nystagmus in patients with vestibular disorders. Otolaryngol Head Neck Surg 2003;129:255–258.
18.
Park H, Shin J, Shim D: Mechanisms of vibration-induced nystagmus in normal subjects and patients with vestibular neuritis. Audiol Neurootol 2007;12:189–197.
19.
Robinson DA: A method of measuring eye movement using a scleral search coil in a magnetic field. IEEE Trans Biomed Eng 1963;10:137–145.
20.
Robinson DA, Zee DS, Hain TC, et al: Alexander’s law: its behaviour and origin in the human vestibule-ocular reflex. Ann Neurol 1984;16:714–722.
21.
Sohmer H, Freeman S, Geal-Dor M, Adelman C, Savion I: Bone conduction experiments in humans: a fluid pathway from bone to ear. Hear Res 2000;146:81–88.
22.
Suzuki JI, Cohen B, Bender MB: Compensatory eye movements induced by vertical semicircular canal stimulation. Exp Neurol 1964;9:137–160.
23.
Suzuki JI, Tokumasu K, Goto K: Eye movements from single utricular nerve stimulation. Acta Otolaryngol 1969;68:350–362.
24.
von Helmholtz H: Helmholtz’s Treatise on Physiological Optics, ed 3 (translated). New York, Dover Publications, 1962.
25.
White JA, Hughes GB, Ruggieri PN: Vibration-induced nystagmus as an office procedure for the diagnosis of superior semicircular canal dehiscence. Otol Neurotol 2007;28:911–916.
26.
Wit HP, Bleeker JD, Mulder HH: Responses of pigeon vestibular nerve fibers to sound and vibration with audiofrequencies. J Acoust Soc Am 1984;75:202–208.
27.
Young ED, Fernandez C: Responses of squirrel monkey vestibular neurons to audio frequency sound and head vibration. Acta Otolaryngol 1977;84:352–360.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.